We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Benign Thyroid Nodules Follow-Up Shows Favorable Prognosis

By LabMedica International staff writers
Posted on 24 Mar 2015
Print article
Image: Fine needle aspiration cytology of a thyroid nodule showing benign epithelial cells, colloid, and occasional macrophages, typical of a colloid nodule (Photo courtesy of Shahidul Islam, MD, PhD).
Image: Fine needle aspiration cytology of a thyroid nodule showing benign epithelial cells, colloid, and occasional macrophages, typical of a colloid nodule (Photo courtesy of Shahidul Islam, MD, PhD).
A majority of asymptomatic, benign thyroid nodules exhibited no significant change in size, after five years of follow-up, or actually decreased in size, and diagnoses of thyroid cancer were rare.

The discovery of a thyroid nodule may be stressful for the patient, but more than 90% of the detected nodules are clinically insignificant benign lesions. Fine-needle aspiration cytology is the procedure of choice to identify suspicious lesions that require thyroid surgery.

Scientists at the Università di Roma Sapienza (Rome, Italy) and colleagues studied the frequency, magnitude, and factors associated with changes in thyroid nodule size. The study involved 992 patients with one to four asymptomatic, sonographically or cytologically benign thyroid nodules. Patients were recruited from eight hospital-based thyroid-disease referral centers in Italy between 2006 and 2008. Data collected during the first five years of follow-up, through January 2013, were analyzed. Size changes were considered significant for growth if an increase of 20% or more was recorded in at least two nodule diameters, with a minimum increase of two mm.

Fine-needle aspiration was performed or repeated when suspicious findings such as hypoechogenicity, irregular margins, taller-than-wide shape, intranodular vascular spots, microcalcifications, developed subsequent to the baseline ultrasound examination. Thyroid function tests were also measured. Nodule growth occurred in 153 patients (15.4%) and 174 of the 1,567 original nodules (11.1%) increased in size. Nodule growth was associated with presence of multiple nodules. In 184 individuals (18.5%), nodules shrank. Thyroid cancer was diagnosed in five original nodules (0.3 %), only two of which had grown. New nodules developed in 93 patients (9.3%), with detection of one cancer.

The authors noted that one of the goals of surveillance is the prompt detection and treatment of thyroid cancers that arise during follow-up or have been missed on the initial assessment. In the population they studied, these events were rare. Only two of the five diagnoses of cancer in an established nodule were preceded by significant growth of the cancerous nodule. Among patients with asymptomatic thyroid nodules that were sonographically or cytologically benign, the majority of nodules exhibited no significant size change during five years of follow-up or they actually decreased in size. The study was published on March 3, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Università di Roma Sapienza


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.